보고서 요약(국문)

개요
전 세계 만성 상처 치료 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
만성 상처는 일련의 단계와 예측 가능한 기간을 거쳐 회복되지 않는 상처, 즉 3개월 이내에 회복되지 않는 상처를 말합니다. 만성 상처는 염증 단계에 너무 오래 머무르는 경우가 많으며, 회복되지 않거나 수년이 걸릴 수 있습니다.
시장 동향: 성장 동인 및 제약 요인
첨단 제품 개발 및 신제품 출시
첨단 제품 개발과 신제품 출시가 예측 기간 동안 전 세계 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 10월 Healiva는 환자의 모발에서 추출한 세포를 기반으로 한 만성 상처 치료용 자가 표피 패치인 EpiDex를 개발했습니다.

또한, 2022년 10월, Healthium Medtech는 당뇨병성 족부 궤양 및 하지 궤양과 같은 만성 상처 관리를 위한 새로운 상처 드레싱 제품 라인인 Theruptor Novo를 출시했습니다. 당뇨병성 궤양 및 혈관성 궤양 발병 사례 증가와 시장 개발의 성장은 예측 기간 동안 세계 시장 성장에 기여할 것으로 예상되는 여러 요인 중 일부입니다.
높은 치료 비용
그러나 장기간에 걸쳐 진행되는 상처 치료의 높은 비용은 규제 당국의 승인에 대한 엄격한 규정, 높은 개발 비용, 전문가 부족과 같은 다른 요인들과 함께 예측 기간 동안 세계 시장 성장을 저해하는 요인으로 작용하고 있습니다.
세분화 분석
세계 만성 상처 관리 시장은 제품 유형, 상처 유형, 최종 사용자 및 지역별로 세분화됩니다.
폼 드레싱 제품 유형이 시장을 주도할 것으로 예상됨
폼 드레싱은 해당 부문의 제품 출시 증가로 인해 예측 기간 동안 세계 시장을 주도할 것으로 예상됩니다. 예를 들어, 2022년 6월 메드라인(Medline)은 옵티폼젠틀 EX(OptifoamGentle EX) 폼 드레싱을 출시했습니다. 이 제품은 욕창 예방 프로토콜과 함께 사용하면 압력을 완화하는 데 도움이 됩니다. 또한, 2022년 5월 위너 메디컬(Winner Medical)은 투명 필름 드레싱, SAF 및 항균 시리즈 제품이 포함된 테두리형 실리콘 폼 드레싱, 카르복시메틸셀룰로오스(CMC) 드레싱과 같은 최첨단 수술 상처 관리 제품을 선보였습니다.
지역 분석
북미, 세계 시장 주도 예상
당뇨병 및 욕창 발생률 증가와 시장 개발의 성장세에 힘입어 북미 시장은 예측 기간 동안 세계 시장을 주도할 것으로 예상됩니다. 예를 들어, 국제당뇨병연맹(International Diabetes Federation)의 당뇨병 아틀라스 10판에 따르면, 2021년 미국에서는 약 3,220만 명이 당뇨병을 앓았으며, 이는 2045년까지 3,630만 명으로 증가할 것으로 예상됩니다.
또한, 국립생명공학정보센터(National Center for Biotechnology Information) 보고서에 따르면, 2021년 12월 미국에서 100만~300만 명에 달하는 상당한 수의 사람들이 욕창을 겪었으며, 이는 효과적인 상처 관리 솔루션의 필요성을 강조합니다. 더 나아가, 케인 바이오테크(Kane Biotech)는 2023년 4월 프로제나케어 글로벌(ProgenaCare Global)과 자사의 항균성 상처 젤의 유통 계약을 체결하여 저렴하고 효과적인 상처 치료 기술에 중점을 두고 미국 내 상처 치료 및 수술 시장에 기술을 제공하기 시작했습니다.
COVID-19 영향 분석
COVID-19 팬데믹 기간 동안 상처 치료 지연은 특히 중요한 문제였습니다. 만성 상처 환자는 일반적으로 당뇨병과 같은 기저 질환을 가지고 있기 때문에 입원 기간 및 사망 측면에서 코로나19로 인한 더 심각한 결과에 노출될 위험이 높습니다. 그러나 팬데믹 이후 상황은 팬데믹 이전 수준으로 돌아가고 있습니다.
시장 세분화
제품 유형별
• 고급 상처 드레싱
o 폼 드레싱
o 하이드로겔 드레싱
o 콜라겐 드레싱
o 기타 드레싱
• 능동적 상처 관리
o 피부 이식
o 성장 인자
• 치료 기기
o 음압 상처 치료 기기
o 압력 완화 기기
o 고압 산소 장비
o 기타 기기
상처 유형별
• 당뇨병성 족부 궤양
• 욕창
• 동맥 및 정맥 궤양
• 기타
최종 사용자별
• 병원
• 외래 수술 센터
• 전문 클리닉
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 동향
• 2022년 9월, 에보닉(Evonik)은 의료 기술 컨설팅 및 판매 기업인 쿱메드(Coopmed)와 상처 드레싱 제품인 에피사이트(Epicite)의 유통 계약을 체결했습니다.

• 2023년 9월, 힐리바(Healiva)는 로잔 대학 병원(CHUV, Centre Hospitalier Universitaire Vaudois)과 자가 유래 표피 유사체인 에피덱스(Epidex)의 제조 및 승인을 위한 전략적 협력을 체결했습니다.

• 2022년 7월, 스미스앤네퓨(Smith Nephew)는 임상 지원 앱인 WOUND COMPASS를 출시했습니다. WOUND COMPASS는 임상의가 부상 검토 및 의사 결정을 내릴 때 진료 편차를 줄이기 위한 완벽한 디지털 자산 도구입니다.
경쟁 환경
주요 글로벌 시장 참여 기업으로는 3M, 카디널 헬스(Cardinal Health Inc.), 콜로플라스트(Coloplast AS), B. 브라운(B. Braun SE), 인테그라 라이프사이언스(Integra Lifesciences), 스미스앤네퓨(Smith & Nephew), 컨바텍 그룹(ConvaTec Group PLC), 묄른리케 헬스케어(Mölnlycke Health Care AB), 존슨앤존슨(Johnson & Johnson), 메드트로닉(Medtronic Plc.) 등이 있습니다.

보고서 구매 이유

• 제품 유형, 상처 유형, 최종 사용자 및 지역별 글로벌 만성 상처 치료 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 만성 상처 치료 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 만성 상처 치료 시장 보고서는 약 61개의 표, 58개의 그림, 184페이지로 구성됩니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Chronic Wound Care market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
A chronic wound is a wound that does not recover in an orderly set of phases and in a predictable amount of period or injuries that do not recover within three months are usually regarded chronic. Chronic wounds usually stay in the inflammatory phase for too long and may never recover or may take years.
Market Dynamics: Drivers & Restraints
Advanced Product Development and New Product Introductions
The advanced product development and new product introductions into the market are expected to boost the global market growth during the forecast period. For instance, in October 2023, Healiva developed EpiDex autologous epidermis patches for the therapy of chronic wounds, based on cells originating from a patient’s hair strands.
Moreover, in October 2022, Healthium Medtech introdined a new wound dressing product line, Theruptor Novo, for the control of chronic wounds such as diabetic foot ulcers and leg ulcers. Additionally, the rise in diabetes ulcer and vascualr ulcer cases cases and growing market developments are among other factors that are expected to contribute to the global market growth during the forecast period.
High Treatment Cost
Nevertheless, the high cost of wound care treatment since the treatment runs for longer duration is hampering the global market growth along with the others factors including stringent regulations for approval from regulatory authorities, high development costs and lack of professionals hampering the global market growth during the forecast period.
Segment Analysis
The global chronic wound care market is segmented based on product type, wound type, end user and region.
Foam Dressing Product Type is Expected to Dominate Market
Foam Dressings are expected to dominate the global market during the forecast period owing to increasing product introductions in the segment. For instance, in June 2022, Medline introduced its OptifoamGentle EX Foam Dressing. When united with a pressure injury prevention protocol, the development is purposed to assist in deposing pressure. Moreover, in May 2022, Winner Medical revealed its latest and industry-leading cutting-edge surgical wound care developments, such as the Transparent Film Dressing, Bordered Silicone Foam Dressing with SAF and Antibiosis Series Products, and the Carboxymethylcellulose (CMC) dressing.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increasing cases of diabetes, pressure injuries, and the increasing market developments are expected to boost the North America market to dominate the global market during the forecast period. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth Edition, in 2021, about 32.2 million individuals in the United States had diabetes, which is projected to increase to 36.3 million by 2045.
Moreover, according to the National Center for Biotechnology Information report, in December 2021 a significant number of 1.0 to 3.0 million individuals in the U.S. suffered from pressure injuries, emphasizing the requirement for efficacious wound management solutions. Further, in April 2023 Kane Biotech formed a distribution arrangement with ProgenaCare Global for its coactive antimicrobial wound gel to get technology to the wound care and surgical markets in the U.S. with an emphasis on inexpensive and effective wound care technologies.
COVID-19 Impact Analysis
Delayed wound care was of special consideration during the COVID‐19 pandemic. Since they usually have underlying comorbidities like diabetes, chronic wound patients are at improved threat for more threatening COVID‐19 consequences in the duration of hospitalization and death. However, post-pandemic the situation is returning to pre-pandemic conditions.
Market Segmentation
By Product Type
• Advanced Wound Dressing
o Foams Dressings
o Hydrogel Dressings
o Collagen Dressings
o Other Dressings
• Active Wound Care
o Skin-grafts
o Growth Factors
• Therapy Devices
o Negative Pressure Wound Therapy Devices
o Pressure Relief Devices
o Hyperbaric Oxygen Equipment
o Other Devices
By Wound Type
• Diabetic Foot Ulcer
• Pressure Ulcer
• Arterial and Venous Ulcer
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In September 2022, Evonik formed an agreement with the medical technology consulting and sales corporation Coopmed for the distribution of the wound dressing Epicite.
• In September 2023, Healiva formed a strategic collaboration with Lausanne University Hospital (CHUV, ‘Centre Hospitalier Universitaire Vaudois’) for the manufacturing and clearance of its autologous epidermal equivalent, Epidex.
• In July 2022 Smith Nephew introduced its clinical support app WOUND COMPASS. The complete digital asset tool for clinicians in injury review and decision-making to decrease variation in practice.
Competitive Landscape
The major global players in the market include 3M Company, Cardinal Health Inc., Coloplast AS, B. Braun SE, Integra Lifesciences, Smith & Nephew, ConvaTec Group PLC, Mölnlycke Health Care AB, Johnson & Johnson and Medtronic Plc. among others.
Why Purchase the Report?
• To visualize the global chronic wound care market segmentation based on product type, wound type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of chronic wound care market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global chronic wound care market report would provide approximately 61 tables, 58 figures and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Wound Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Advanced Product Development and New Product Introductions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Treatment Cost
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology Trend
5.6. Unmet Need
5.7. Epidemiology Analysis
5.8. SWOT Analysis
5.9. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Advanced Wound Dressing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Foams Dressings
7.3.1. Hydrogel Dressings
7.3.2. Collagen Dressings
7.3.3. Other Dressings
7.4. Active Wound Care
7.4.1. Skin-grafts
7.4.2. Growth Factors
7.5. Therapy Devices
7.5.1. Negative Pressure Wound Therapy Devices
7.5.2. Pressure Relief Devices
7.5.3. Hyperbaric Oxygen Equipment
7.5.4. Other Devices
8. By Wound Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
8.1.2. Market Attractiveness Index, By Wound Type
8.2. Diabetic Foot Ulcer*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pressure Ulcer
8.4. Arterial and Venous Ulcer
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. 3M Company, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Cardinal Health Inc.
12.3. Coloplast AS, Inc.
12.4. B. Braun SE
12.5. Integra Lifesciences
12.6. Smith & Nephew,
12.7. ConvaTec Group PLC
12.8. Mölnlycke Health Care AB
12.9. Johnson & Johnson
12.10. MEDTRONIC PLC.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

3M Company, Inc., 4.	Key Developments, Cardinal Health Inc., Coloplast AS, Inc., B. Braun SE, Integra Lifesciences, Smith & Nephew,, ConvaTec Group PLC, Mölnlycke Health Care AB, Johnson & Johnson, MEDTRONIC PLC.

표 목록 (Tables)

List of Tables

Table 1 Global Chronic Wound Care Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Chronic Wound Care Market Value, By Wound Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Chronic Wound Care Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Chronic Wound Care Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Chronic Wound Care Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Chronic Wound Care Market Value, By Wound Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 9 Global Chronic Wound Care Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Chronic Wound Care Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Chronic Wound Care Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 15 North America Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Chronic Wound Care Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 19 South America Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Chronic Wound Care Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 23 Europe Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Chronic Wound Care Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Chronic Wound Care Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Chronic Wound Care Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Chronic Wound Care Market Value, By Wound Type, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Chronic Wound Care Market Value, By End User, 2022-2031 (US$ Million)

Table 32 3M Company, Inc.: Overview

Table 33 3M Company, Inc.: Product Portfolio

Table 34 3M Company, Inc.: Key Developments

Table 35 Cardinal Health Inc.: Overview

Table 36 Cardinal Health Inc.: Product Portfolio

Table 37 Cardinal Health Inc.: Key Developments

Table 38 Coloplast AS, Inc.: Overview

Table 39 Coloplast AS, Inc.: Product Portfolio

Table 40 Coloplast AS, Inc.: Key Developments

Table 41 B. Braun SE: Overview

Table 42 B. Braun SE: Product Portfolio

Table 43 B. Braun SE: Key Developments

Table 44 Integra Lifesciences: Overview

Table 45 Integra Lifesciences: Product Portfolio

Table 46 Integra Lifesciences: Key Developments

Table 47 Smith & Nephew: Overview

Table 48 Smith & Nephew: Product Portfolio

Table 49 Smith & Nephew: Key Developments

Table 50 ConvaTec Group PLC: Overview

Table 51 ConvaTec Group PLC: Product Portfolio

Table 52 ConvaTec Group PLC: Key Developments

Table 53 Mölnlycke Health Care AB: Overview

Table 54 Mölnlycke Health Care AB: Product Portfolio

Table 55 Mölnlycke Health Care AB: Key Developments

Table 56 Johnson & Johnson: Overview

Table 57 Johnson & Johnson: Product Portfolio

Table 58 Johnson & Johnson: Key Developments

Table 59 MEDTRONIC PLC.: Overview

Table 60 MEDTRONIC PLC.: Product Portfolio

Table 61 MEDTRONIC PLC.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 2 Global Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 4 Global Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Chronic Wound Care Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Chronic Wound Care Market Y-o-Y Growth, By Product Type, 2022- 2031 (%)

Figure 7 Advanced Wound Dressing Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 8 Active Wound Care Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 9 Therapy Devices Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 10 Global Chronic Wound Care Market Y-o-Y Growth, By Wound Type, 2022- 2031 (%)

Figure 11 Diabetic Foot Ulcer Wound Type in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 12 Pressure Ulcer Wound Type in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 13 Arterial and Venous Ulcer Wound Type in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 14 Others Wound Type in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 15 Global Chronic Wound Care Market Y-o-Y Growth, By End User, 2022- 2031 (%)

Figure 16 Hospitals End User in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 17 Ambulatory Surgical Centers End User in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 18 Specialty Clinics End User in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 19 Others End User in Global Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 20 Global Chronic Wound Care Market Y-o-Y Growth, By Region, 2022- 2031 (%)

Figure 21 North America Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 22 Asia-Pacific Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 23 Europe Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 24 South America Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 25 Middle East and Africa Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 26 North America Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 27 North America Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 28 North America Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 29 North America Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 30 North America Chronic Wound Care Market Share, By Country, 2022 & 2031 (%)

Figure 31 South America Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 32 South America Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 33 South America Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 34 South America Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 35 South America Chronic Wound Care Market Share, By Country, 2022 & 2031 (%)

Figure 36 Europe Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 37 Europe Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 38 Europe Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 39 Europe Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 40 Europe Chronic Wound Care Market Share, By Country, 2022 & 2031 (%)

Figure 41 Asia-Pacific Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 42 Asia-Pacific Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Asia-Pacific Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 44 Asia-Pacific Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 45 Asia-Pacific Chronic Wound Care Market Share, By Country, 2022 & 2031 (%)

Figure 46 Middle East & Africa Chronic Wound Care Market Value, 2022-2031 (US$ Million)

Figure 47 Middle East & Africa Chronic Wound Care Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Middle East & Africa Chronic Wound Care Market Share, By Wound Type, 2022 & 2031 (%)

Figure 49 Middle East & Africa Chronic Wound Care Market Share, By End User, 2022 & 2031 (%)

Figure 50 3M Company, Inc.: Financials

Figure 51 Cardinal Health Inc.: Financials

Figure 52 Coloplast AS, Inc.: Financials

Figure 53 B. Braun SE: Financials

Figure 54 Integra Lifesciences: Financials

Figure 55 Smith & Nephew, Financials

Figure 56 ConvaTec Group PLC: Financials

Figure 57 Mölnlycke Health Care AB: Financials

Figure 58 Johnson & Johnson: Financials

Figure 59 MEDTRONIC PLC.: Financials

세계 만성 상처 치료 시장 – 2023-2030

Global Chronic Wound Care Market - 2023-2030